10 de June de 2026

When Should Validation Begin in Regulated Projects?

Many companies still believe validation begins only during the testing phase, but this decision can lead to rework, delays, increased costs, and regulatory risks. Discover why validation should start in the early stages of regulated projects and how a proactive approach can improve efficiency, ensure compliance, and prevent issues in CSV, process validation, and cleaning validation initiatives.
2 de June de 2026

Validation 4.0 Is Not Just Digital Validation: It’s a Shift in How We Ensure Quality

Pharmaceutical manufacturing depends on consistent quality, safety, and efficacy. As advanced therapies, digital technologies, and complex production environments reshape the industry, traditional validation approaches are evolving. Discover how Validation 4.0 is transforming process validation through data-driven strategies, continuous monitoring, and digital innovation.
9 de December de 2025

How are you viewing Digital Validation

How are you viewing this as just another system to implement? Digital transformation has accelerated faster than most organizations anticipated. Some companies have already positioned themselves ahead of the curve, embracing digital validation not as an operational detail, but as a strategic enabler.
10 de July de 2025

Pharma 4.0: Building Smart Factories Through Integration and Validation

In recent years, many leaders in the Life Sciences industry have heard the same message over and over: “You need to apply AI and Machine Learning now, or your competitors will, and they’ll make faster, smarter decisions.” It sounds convincing. And it’s true: data-driven decision-making has the power to replace assumptions and intuition with insights based on real patterns.
30 de October de 2024

IT and OT Qualification for AI and Traditional Technologies

In Life Sciences companies, AI is being used for tasks such as automating manufacturing processes, optimizing clinical trials, analyzing patient data and several other critical applications for the pharmaceutical, biotechnology and medical products industries.
24 de October de 2024

Data Governance for AI

Life Sciences companies, particularly biopharmaceutical and medical product companies, are highly regulated and need to prove that their product and its manufacturing and development processes are robust. Patient safety is impacted by the integrity of critical records, data, and decisions, as well as aspects related to the physical attributes of the products.
4 de October de 2024

How to Validate AI in GxP Applications for Life Science Companies

The integration of Artificial Intelligence (AI) into the Life Sciences industry brings innovative potential, from drug discovery to personalized medicine. However, incorporating AI into GxP (Good Practice) environments, which are governed by regulations to ensure product safety and efficacy, introduces additional challenges in AI validation.